About FDA
Number of documents reviewed for CT and ET policy development in the month
Dictionary: As a key agency protecting the public’s health, FDA is asked to provide input into inter and intra-agency countermeasure development activities. One coordinated voice from the agency insures consistent responses, minimizing confusion on agency policy. Consistent communication and input of agency policy minimizes opportunities for hindering the deployment of medical countermeasures to the public.
Fiscal Year - 2010
| Time | Target | Number of Documents |
|---|---|---|
| Oct 2009 | N/A | N/A |
| Nov 2009 | N/A | N/A |
| Dec 2009 | N/A | N/A |
| Jan 2010 | N/A | N/A |
| Feb 2010 | N/A | N/A |
| Mar 2010 | N/A | N/A |
| Apr 2010 | N/A | 16 |
| May 2010 | N/A | 15 |
| Jun 2010 | N/A | 29 |
| Jul 2010 | N/A | 6 |
| Aug 2010 | N/A | 20 |
| Sep 2010 | N/A | 22 |
FY 2010 6-Month Total: 108
Glossary
Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.
